<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-8ZD2FBDX/7a5dd5a2-528f-49e8-86c2-13c12061858c/HTML"><dcterms:extent>22 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-8ZD2FBDX/373a4565-f8ca-4195-aff1-bcf2355b862d/PDF"><dcterms:extent>96 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-8ZD2FBDX/6c92d91c-5a8a-4d01-ae41-02a804282e40/TEXT"><dcterms:extent>17 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-8ZD2FBDX"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2002</dcterms:issued><dc:creator>Lavre, Janez</dc:creator><dc:creator>Vodopija, Nado</dc:creator><dc:creator>Vujkovac, Bojan</dc:creator><dc:format xml:lang="sl">številka:1</dc:format><dc:format xml:lang="sl">letnik:71</dc:format><dc:format xml:lang="sl">str. 11-13</dc:format><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID:5381940</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-8ZD2FBDX</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">Avtorji domačini</dc:subject><dc:subject xml:lang="sl">Dializni bolniki</dc:subject><dc:subject xml:lang="sl">erekcija</dc:subject><dc:subject xml:lang="sl">Erektilna disfunkcija</dc:subject><dc:subject xml:lang="sl">Hemodializa</dc:subject><dc:subject xml:lang="sl">Koroška krajina</dc:subject><dc:subject xml:lang="sl">motnje</dc:subject><dc:subject xml:lang="sl">Sildenafil</dc:subject><dc:subject xml:lang="sl">Viagra</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Sildenafil (viagra) izboljša erektilno disfunkcijo pri dializnih bolnikih - naše prve izkušnje| Use of sildenafil (Viagra) for erectile dysfunction in dialysis patients - our first experience|</dc:title><dc:description xml:lang="sl">Background. Male patients with end stage renal disease often report erectile dysfunction, which is very common especially in younger males. Impotence is reported to exceed 50% in male chronic renal failure patients, and is present in 65% of such patients undergoing hemodialysis. Numerous etiological factors have been reported as possible cause for sexual dysfunction. Sildenafil (Viagra), a potent specific inhibitor of cGMP phosphodiesterase, was used in this case study to improve erectile dysfunction in dialysis male patients. Methods and results. During 12 weeks we treated 4 dialysis patients. 2 patients were treated with peritoneal dialysis and 2 patients were in the program of chronic hemodialysis. All patients were in the program of dialysis for more than 24 months, and reported erectile dysfunction and impotence afterthey had started with dialysis treatment. Sildenafil was used in the treatment The dosage schedule for sildenafil was 50mgž week orally for 2 weeksfollowed by 100 mgžweek for the next 10 weeks if there was no effect on initial dosage. Efficacy of treatment was evaluated by means of the International lndex of Erectile Dysfunction. All 4 patients reported no significant effect on initial dose. With higher dose of sildenafil treatment was overwhelmingly successful, with reported prolonged improvement of erectiledysfunction for 42 to 72 hours. Side effects were present only in 1 patient who had severe headaches after higher dose. No patients experienced priapism. Conclusions. There have been only few reports in the literature on the use of sildenafil in dialysis patients. Our small case study suggests thatsildenafil could be successfully and safely used for treatment of erectiledysfunction also in dialysis patients. A large trial would be necessary to confirm the efficacy of the drug for this specific group of patients</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-8ZD2FBDX"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-8ZD2FBDX" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-8ZD2FBDX/373a4565-f8ca-4195-aff1-bcf2355b862d/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-8ZD2FBDX/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-8ZD2FBDX" /></ore:Aggregation></rdf:RDF>